ASO Author Reflections: Gene Expression-Profiling and Implications for Adjuvant Therapy in Melanoma.
作者信息
Farrow Norma E, Beasley Georgia M
机构信息
Department of Surgery, Duke University, Durham, USA.
出版信息
Ann Surg Oncol. 2021 Jul;28(7):3511. doi: 10.1245/s10434-021-09595-7. Epub 2021 Jan 22.
Abstract
摘要
相似文献
1
ASO Author Reflections: Gene Expression-Profiling and Implications for Adjuvant Therapy in Melanoma.《美国骨科学会作者反思：黑色素瘤中的基因表达谱分析及其对辅助治疗的影响》
Ann Surg Oncol. 2021 Jul;28(7):3511. doi: 10.1245/s10434-021-09595-7. Epub 2021 Jan 22.
2
ASO Author Reflections: Gene Expression Profiling for Melanoma: Is it Ready for Prime Time?《美国眼科学会作者反思：黑色素瘤的基因表达谱分析：它准备好进入黄金时代了吗？》
Ann Surg Oncol. 2021 Aug;28(8):4590-4591. doi: 10.1245/s10434-021-09599-3. Epub 2021 Jan 21.
3
ASO Author Reflections: Is There a Re-invigorated Role for Melanoma Metastasectomy in a Checkpoint Blockade Era?ASO作者反思：在检查点阻断疗法时代，黑色素瘤转移灶切除术是否有重新焕发活力的作用？
Ann Surg Oncol. 2020 Apr;27(4):1189-1190. doi: 10.1245/s10434-020-08201-6. Epub 2020 Jan 17.
4
ASO Author Reflections: Frequent Relapses Prior to the Start of Adjuvant Therapy in Stage IIIB/C Melanoma.ASO作者反思：IIIB/C期黑色素瘤辅助治疗开始前频繁复发
Ann Surg Oncol. 2019 Nov;26(12):3953-3954. doi: 10.1245/s10434-019-07665-5. Epub 2019 Aug 8.
5
ASO Author Reflections: Adjuvant Treatment of Melanoma in the Modern Era.美国骨科学会作者反思：现代黑色素瘤的辅助治疗
Ann Surg Oncol. 2020 Dec;27(13):5137-5138. doi: 10.1245/s10434-020-08671-8. Epub 2020 May 28.
6
ASO Author Reflections: Survival for Stage III Melanoma-Where Do We Stand in the Current Landscape of Melanoma Therapies?ASO作者反思：III期黑色素瘤的生存——在当前黑色素瘤治疗格局中我们处于什么位置？
Ann Surg Oncol. 2019 Dec;26(13):4631-4632. doi: 10.1245/s10434-019-07888-6. Epub 2019 Oct 1.
7
ASO Author Reflections: What Role Do Surgeons Play in the Era of Effective Systemic Therapy for Melanoma?ASO作者反思：在黑色素瘤有效全身治疗时代，外科医生扮演着怎样的角色？
Ann Surg Oncol. 2019 Dec;26(13):4619-4620. doi: 10.1245/s10434-019-07711-2. Epub 2019 Sep 17.
8
ASO Author Reflections: International Experience of Isolated Limb Infusion for Melanoma Shows Durable Response.
Ann Surg Oncol. 2019 Aug;26(8):2495-2496. doi: 10.1245/s10434-019-07435-3. Epub 2019 May 13.
9
ASO Author Reflections: Neoadjuvant Treatment for Melanoma-Where Are We Now?ASO作者反思：黑色素瘤的新辅助治疗——我们目前的进展如何？
Ann Surg Oncol. 2022 Dec;29(13):8501-8502. doi: 10.1245/s10434-022-12308-3. Epub 2022 Jul 26.
10
ASO Author Reflections: The Landmark Series: Neoadjuvant Systemic Therapy (NAST) for Stage 3 Melanoma Patients: A Potential Paradigm Shift in Management.ASO作者反思：里程碑系列：3期黑色素瘤患者的新辅助全身治疗（NAST）：治疗模式的潜在转变。
Ann Surg Oncol. 2020 Jul;27(7):2201-2202. doi: 10.1245/s10434-020-08570-y. Epub 2020 May 7.
本文引用的文献
1
Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma.Sentinel 淋巴结免疫特征的表征及其对黑色素瘤辅助治疗风险分层的影响。
Ann Surg Oncol. 2021 Jul;28(7):3501-3510. doi: 10.1245/s10434-020-09277-w. Epub 2020 Nov 17.
Zotero 插件